Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma

Pancreatic cancer is one of the tumors with a poor prognosis. Therefore, it is significant and urgent to explore effective biomarkers for risk stratification and prognosis prediction to promote individualized treatment and prolong the survival of patients with PAAD. In this study, we identified Wnt/...

Full description

Bibliographic Details
Main Authors: Hao Lyu, Jiahui Zhang, Qian Wei, Yuan Huang, Rui Zhang, Shuai Xiao, Dong Guo, Xing-Zhen Chen, Cefan Zhou, Jingfeng Tang
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Biology
Subjects:
Online Access:https://www.mdpi.com/2079-7737/12/2/319
_version_ 1827758478199881728
author Hao Lyu
Jiahui Zhang
Qian Wei
Yuan Huang
Rui Zhang
Shuai Xiao
Dong Guo
Xing-Zhen Chen
Cefan Zhou
Jingfeng Tang
author_facet Hao Lyu
Jiahui Zhang
Qian Wei
Yuan Huang
Rui Zhang
Shuai Xiao
Dong Guo
Xing-Zhen Chen
Cefan Zhou
Jingfeng Tang
author_sort Hao Lyu
collection DOAJ
description Pancreatic cancer is one of the tumors with a poor prognosis. Therefore, it is significant and urgent to explore effective biomarkers for risk stratification and prognosis prediction to promote individualized treatment and prolong the survival of patients with PAAD. In this study, we identified Wnt/β-catenin- and autophagy-related long non-coding RNAs (lncRNAs) and demonstrated their role in predicting immune efficacy for PAAD patients. The univariate and multivariate Cox proportional hazards analyses were used to construct a prognostic risk model based on six autophagy- and Wnt/β-catenin-related lncRNAs (warlncRNAs): LINC01347, CASC8, C8orf31, LINC00612, UCA1, and GUSBP11. The high-risk patients were significantly associated with poor overall survival (OS). The receiver operating characteristic (ROC) curve analysis was used to assess the predictive accuracy of the prognostic risk model. The prediction efficiency was supported by the results of an independent validation cohort. Subsequently, a prognostic nomogram combining warlncRNAs with clinical indicators was constructed and showed a good predictive efficiency for survival risk stratification. Furthermore, functional enrichment analysis demonstrated that the signature according to warlncRNAs is closely linked to malignancy-associated immunoregulatory pathways. Correlation analysis uncovered that warlncRNAs’ signature was considerably associated with immunocyte infiltration, immune efficacy, tumor microenvironment score, and drug resistance.
first_indexed 2024-03-11T09:08:00Z
format Article
id doaj.art-65ef7f6b9df849ecaeae0e0ae301e2cc
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-11T09:08:00Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-65ef7f6b9df849ecaeae0e0ae301e2cc2023-11-16T19:14:48ZengMDPI AGBiology2079-77372023-02-0112231910.3390/biology12020319Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic AdenocarcinomaHao Lyu0Jiahui Zhang1Qian Wei2Yuan Huang3Rui Zhang4Shuai Xiao5Dong Guo6Xing-Zhen Chen7Cefan Zhou8Jingfeng Tang9Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, ChinaCooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, ChinaCooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, ChinaCooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, ChinaNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, ChinaNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, ChinaNational “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, ChinaMembrane Protein Disease Research Group, Department of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, CanadaCooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, ChinaCooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan 430068, ChinaPancreatic cancer is one of the tumors with a poor prognosis. Therefore, it is significant and urgent to explore effective biomarkers for risk stratification and prognosis prediction to promote individualized treatment and prolong the survival of patients with PAAD. In this study, we identified Wnt/β-catenin- and autophagy-related long non-coding RNAs (lncRNAs) and demonstrated their role in predicting immune efficacy for PAAD patients. The univariate and multivariate Cox proportional hazards analyses were used to construct a prognostic risk model based on six autophagy- and Wnt/β-catenin-related lncRNAs (warlncRNAs): LINC01347, CASC8, C8orf31, LINC00612, UCA1, and GUSBP11. The high-risk patients were significantly associated with poor overall survival (OS). The receiver operating characteristic (ROC) curve analysis was used to assess the predictive accuracy of the prognostic risk model. The prediction efficiency was supported by the results of an independent validation cohort. Subsequently, a prognostic nomogram combining warlncRNAs with clinical indicators was constructed and showed a good predictive efficiency for survival risk stratification. Furthermore, functional enrichment analysis demonstrated that the signature according to warlncRNAs is closely linked to malignancy-associated immunoregulatory pathways. Correlation analysis uncovered that warlncRNAs’ signature was considerably associated with immunocyte infiltration, immune efficacy, tumor microenvironment score, and drug resistance.https://www.mdpi.com/2079-7737/12/2/319long non-coding RNAautophagyWnt/β-cateninprognosispancreatic adenocarcinoma
spellingShingle Hao Lyu
Jiahui Zhang
Qian Wei
Yuan Huang
Rui Zhang
Shuai Xiao
Dong Guo
Xing-Zhen Chen
Cefan Zhou
Jingfeng Tang
Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
Biology
long non-coding RNA
autophagy
Wnt/β-catenin
prognosis
pancreatic adenocarcinoma
title Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
title_full Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
title_fullStr Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
title_full_unstemmed Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
title_short Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
title_sort identification of wnt β catenin and autophagy related lncrna signature for predicting immune efficacy in pancreatic adenocarcinoma
topic long non-coding RNA
autophagy
Wnt/β-catenin
prognosis
pancreatic adenocarcinoma
url https://www.mdpi.com/2079-7737/12/2/319
work_keys_str_mv AT haolyu identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT jiahuizhang identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT qianwei identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT yuanhuang identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT ruizhang identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT shuaixiao identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT dongguo identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT xingzhenchen identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT cefanzhou identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma
AT jingfengtang identificationofwntbcateninandautophagyrelatedlncrnasignatureforpredictingimmuneefficacyinpancreaticadenocarcinoma